Kezar Life Sciences

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell KZR and other ETFs, options, and stocks.

About KZR

Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer. Its product pipeline includes KZR-616, KZR-261, and KZR-TBD.

CEO

Christopher J. Kirk

CEOChristopher J. Kirk

Employees

Employees55

Headquarters

South San Francisco, California

HeadquartersSouth San Francisco, California

Founded

2015

Founded2015

Employees

Employees55

KZR Key Statistics

Market cap

32.51M

Market cap32.51M

Price-Earnings ratio

-0.41

Price-Earnings ratio-0.41

Dividend yield

—

Dividend yield—

Average volume

14.18K

Average volume14.18K

High today

$4.45

High today$4.45

Low today

$4.40

Low today$4.40

Open price

$4.45

Open price$4.45

Volume

8.41K

Volume8.41K

52 Week high

$9.18

52 Week high$9.18

52 Week low

$3.62

52 Week low$3.62

People also own

Based on the portfolios of people who own KZR. This list is generated using Robinhood data, and it’s not a recommendation.